Cellectis (CLLS) FCF Margin Growth (3y) (2018 - 2026)
Cellectis (CLLS) FCF Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cellectis |
17.40 Bn |
17.21 Bn |
- |
2.00 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
2.00 Mn |
| Dec 31, 2025 |
-6,107.00 |
| Sep 30, 2025 |
1.46 Mn |
| Jun 30, 2025 |
167,346.00 |
| Mar 31, 2025 |
200,398.00 |
| Dec 31, 2024 |
54,119.00 |
| Sep 30, 2024 |
27,937.00 |
| Jun 30, 2024 |
71,992.00 |
| Mar 31, 2024 |
-38,221.00 |
| Dec 31, 2023 |
1.57 Mn |
| Sep 30, 2023 |
-1.05 Mn |
| Jun 30, 2023 |
-1.03 Mn |
| Mar 31, 2023 |
-2.02 Mn |
| Dec 31, 2022 |
55,427.00 |
| Sep 30, 2022 |
-1.44 Mn |
| Jun 30, 2022 |
-15,203.00 |
| Mar 31, 2022 |
-17,426.00 |
| Dec 31, 2021 |
230,128.00 |
| Sep 30, 2021 |
121,031.00 |
| Jun 30, 2021 |
8,402.00 |
